Showing results (121-130 of 447) with videos related to
Sort By:
Pageof 45
Circulation|September 16, 2009
Analysis of stroke in ATHENA: a placebo-controlled, double-blind, parallel-arm trial to assess the efficacy of dronedarone 400 mg BID for the prevention of cardiovascular hospitalization or death from any cause in patients with atrial fibrillation/atrial flutterStuart J Connolly, Harry J G M Crijns, Christian Torp-Pedersen, et al.Journal of the American College of Emergency Physicians Open|March 14, 2022
Thirty-day mortality with andexanet alfa compared with prothrombin complex concentrate therapy for life-threatening direct oral anticoagulant-related bleedingAlexander T Cohen, Megan Lewis, Augusta Connor, et al.International Journal of Cardiology|May 15, 2007
Potential demographic and baselines variables for risk stratification of high-risk post-myocardial infarction patients in the era of implantable cardioverter-defibrillator--a prognostic indicatorYee Guan Yap, Trinh Duong, Martin Bland, et al.The American Journal of Cardiology|July 11, 2006
Efficacy of azimilide for the maintenance of sinus rhythm in patients with paroxysmal atrial fibrillation in the presence and absence of structural heart diseaseCharles R Kerr, Stuart J Connolly, Peter Kowey, et al.The New England Journal of Medicine|December 14, 2004
Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarctionStefan H Hohnloser, Karl Heinz Kuck, Paul Dorian, et al.American Heart Journal|December 19, 2015
Interleukin-6 and C-reactive protein and risk for death and cardiovascular events in patients with atrial fibrillationJulia Aulin, Agneta Siegbahn, Ziad Hijazi, et al.TH Open : Companion Journal to Thrombosis and Haemostasis|June 29, 2019
Apixaban-Calibrated Anti-FXa Activity in Relation to Outcome Events and Clinical Characteristics in Patients with Atrial Fibrillation: Results from the AVERROES TrialVinai C Bhagirath, John W Eikelboom, Jack Hirsh, et al.Clinical Cardiology|November 9, 2005
Prognostic impact of demographic factors and clinical features on the mode of death in high-risk patients after myocardial infarction--a combined analysis from multicenter trialsYee Guan Yap, Trinh Duong, J Martin Bland, et al.Heart Rhythm|August 19, 2014
Prospective long-term evaluation of Optim-insulated (Riata ST Optim and Durata) implantable cardioverter-defibrillator leadsJohn A Cairns, Andrew E Epstein, John Rickard, et al.Thrombosis and Haemostasis|October 4, 2020
Long-Term Treatment with Apixaban in Patients with Atrial Fibrillation: Outcomes during the Open-Label Extension following AVERROESAlexander P Benz, John W Eikelboom, Salim Yusuf, et al.Pageof 45